参考文献/References:
[1] 鲁建军,潘游,雷艺炎,等.真核细胞翻译起始因子和雷帕霉素靶蛋白在食管鳞癌组织中表达的临床意义[J].中华胃肠外科杂志,2015,18(9):905-908.
[2] KARAKI S,ANDRIEU C,ZIOUZIOU H,et al.The eukaryotic translation initiation factor 4E (eIF4E) as a therapeutic target for cancer[J].Adv Protein Chem Struct Biol,2015,101:1-26.
[3] KODALI D,RAWAL A,NINAN M J,et al.Expression and phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 in B-cell lymphomas and reactive lymphoid tissues[J].Arch Pathol Lab Med,2011,135(3):365-371.
[4] 鲍启德,张长江,刘敏,等.食管癌临床症状类型及其年龄和性别分布特征[J].新乡医学院学报,2017,34(7):570-573,578.
[5] QIN X,JIANG B,ZHANG Y.4E-BP1,a multifactor regulated multifunctional protein[J].Cell Cycle,2016,15(6):781-786.
[6] MCCLUSKY D R,CHU Q,YU H,et al.A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-positive breast cancer[J].Ann Surg,2005,242(4):584-590.
[7] LU C,MAKALA L,CAI D W Y.Targeting translation:eIF4E as an emerging anticancer drug target[J].Expert Rev Mol Med,2016,18:e2.
[8] SIDDIQUI N,SONENBERG N.Signalling to eIF4E in cancer[J].Biochem Soc Trans,2015,43(5):763-772.
[9] DONG K,WANG R,WANG X,et al.Tumor-specific RNAi targeting eIF4E suppresses tumor rowth,induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells[J].Breast Cancer Res Treat,2009,113(3):443-456.
[10] HSU H S,CHEN H W,KAO C L,et al.MDM2 is overexpressed and regulated by the eukaryotic translation initiation factor 4E (eIF4E) in human squamous cell carcinoma of esophagus[J].Ann Surg Oncol,2011,18(5):1469-1477.
[11] JIANG X M,YU X N,HUANG R Z,et al.Prognostic significance of eukaryotic initiation factor 4E in hepatocellular carcinoma[J].J Cancer Res Clin Oncol,2016,142(11):2309-2317.
[12] 常丽,刘卓,王玉平,等.闭塞性细支气管炎患儿血清血管内皮生长因子的表达及其与病程的相关性[J].中华实用儿科临床杂志,2016,31(12):947-948.
[13] 王志超,邱玉琴,徐伟立,等.化疗对切除困难小儿实体肿瘤血管生成的影响[J].中华实用儿科临床杂志,2014,29(6):474-477.
[14] CREW J P,FUGGLE S,BICKNELL R,et al.Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression[J].Br J Cancer,2000,82(1):161-166.
[15] 赵世巧,陈忠余,邓玮,等.eIF4E、VEGF-A和VEGF-C在胃癌组织中的表达及其与淋巴结侵袭转移的相关性[J].国际检验医学杂志,2015,36(20):2937-2940.
相似文献/References:
[1]原志庆,王凤荣,吴国祥,等.食管癌切除标本断端残留癌的流式细胞分析[J].新乡医学院学报,1991,8(01):012.
[2]彭明轩,张一峰.食管癌与贲门癌238例手术治疗及其并发症分析[J].新乡医学院学报,1992,9(01):048.
[3]刘玉梅,申维玺,姚卫华,等.氟尿嘧啶合并醛氢叶酸治疗食管癌疗效评价[J].新乡医学院学报,1995,12(02):123.
[4]原志庆,许春雷.瘤体内DNA倍体异质性与食管鳞状细胞癌病理特性的关系[J].新乡医学院学报,1995,12(01):005.
[5]常银江,马森林,王守义,等.上段食管癌切除后食管床内胃食管颈部吻合术[J].新乡医学院学报,1996,13(02):143.
[6]王俊英,李国群,董长宪,等.食管癌合并糖尿病患者的围手术期处理[J].新乡医学院学报,1996,13(02):151.
[7]陈国荣.中晚期食管癌夹心治疗近期疗效分析 [J].新乡医学院学报,1997,14(02):150.
[8]李慧清,李汉臣,杨红伟,等.不同食管胃吻合方法术后生活质量分析[J].新乡医学院学报,1997,14(03):213.
[9]郭玉军,吴阶清,刘新秋,等.双介入疗法治疗晚期食管癌[J].新乡医学院学报,1997,14(03):287.
[10]乔 刚 李汉臣 席红军 王忠民 崔 玉 韩培立 赵宝生.食管癌患者手术前后细胞免疫的变化[J].新乡医学院学报,1999,16(04):308.